Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

648
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
648
Cancer Prevention02:59

Cancer Prevention

7.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.7K
Teratogenicity01:07

Teratogenicity

4.0K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.0K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

3.9K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply to: The Role of Risk-Reducing Bilateral Mastectomy in <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variant Carriers.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Risk-reducing surgery, risk-reducing medication, and surveillance in young <i>BRCA</i> carriers with breast cancer: considering all the options.

Translational cancer research·2026
Same author

Survival Outcomes With or Without Risk-Reducing Mastectomy in <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variant Carriers.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Validation of the pathology-adjusted Manchester scoring system in over 10 000 assessments of cases with breast and/or ovarian cancer.

Journal of medical genetics·2025
Same author

Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trial.

Nature communications·2025
Same author

Cost-Effectiveness of Medical Cannabis Versus Opioids for Chronic Noncancer Pain.

Cannabis and cannabinoid research·2025

Related Experiment Video

Updated: Jan 16, 2026

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

13.8K

Pregnancy Associated Breast Cancer: An Australian Perspective.

Caroline MacCallum1,2, Maryam Badawy1,3, Anne C Armstrong4,5

  • 1Prevent Breast Cancer Centre, Manchester University NHS Foundation Trust, Manchester, UK.

ANZ Journal of Surgery
|September 30, 2025
PubMed
Summary

Pregnancy associated breast cancer (PABC) is increasing with maternal age. This review covers the latest evidence on diagnosing and surgically managing PABC in Australasia, balancing maternal treatment with fetal risks.

More Related Videos

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
09:36

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats

Published on: October 16, 2010

30.2K
Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
09:25

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

27.5K

Related Experiment Videos

Last Updated: Jan 16, 2026

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

13.8K
Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
09:36

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats

Published on: October 16, 2010

30.2K
Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
09:25

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

27.5K

Area of Science:

  • Oncology
  • Obstetrics & Gynecology
  • Surgical Oncology

Background:

  • Pregnancy associated breast cancer (PABC) is uncommon but rising due to increased maternal age.
  • Diagnosing and managing PABC presents unique challenges, balancing maternal treatment efficacy with fetal well-being.
  • Optimal care requires careful consideration of treatment timing and modality to minimize risks to both mother and fetus.

Purpose of the Study:

  • To review the current evidence for diagnosing and managing PABC.
  • To provide guidance on surgical care for PABC in an Australasian setting.
  • To address the complexities of PABC treatment in pregnant patients.

Main Methods:

  • Literature review of recent studies on PABC diagnosis and management.
  • Focus on evidence relevant to the Australasian healthcare context.
  • Synthesis of information regarding surgical interventions and patient care.

Main Results:

  • Increasing maternal age is a significant factor in PABC incidence.
  • Multidisciplinary care is crucial for effective PABC management.
  • Surgical strategies must consider gestational stage and treatment protocols.

Conclusions:

  • Early and accurate diagnosis of PABC is essential.
  • Tailored surgical and oncological treatment plans are necessary for PABC patients.
  • Further research is needed to optimize outcomes for mothers and infants affected by PABC.